The application through which a sponsor seeks FDA approval to market a new brand-name drug.
An NDA carries the full preclinical and clinical evidence package. Products approved this way appear in FDA data with marketing category NDA and an application number beginning NDA.
The application number, not the NDC, is what links a brand to its generics: an ANDA references the NDA it is bioequivalent to.